title: Current Perspectives on rosuvastatin.
abstract: Rosuvastatin is one of the most potent statins available for reducing circulating low-density lipoprotein cholesterol (LDL-C) levels, which enables more high-risk patients to achieve their lipid goals. Its favorable balance of effects on atherogenic and protective lipoproteins and its pleiotropic effects, including anti-inflammatory and antioxidant effects and improvement in endothelial dysfunction, are associated with slowing of progression of atherosclerosis within the artery wall and have been translated into clinical benefits for cardiovascular outcomes. This review provides an update on the safety and the efficacy of rosuvastatin in recent large clinical trials. It appears that rosuvastatin has a beneficial effect on the progression of atherosclerosis across the clinical dosage range of 2.5-40 mg. It reduced cardiovascular events in relatively low-risk subjects with elevated high-sensitivity C-reactive protein and normal low-density lipoprotein cholesterol. As with other statins, rosuvastatin did not show overall benefit in terms of survival in patients with heart failure, but certain clinical or biochemical markers reflecting underlying disease characteristics may help to identify subgroups of patients that benefit from statin therapy. In patients with end-stage renal disease undergoing chronic hemodialysis, rosuvastatin had no effect on reducing cardiovascular events. Although there is a slightly increased risk of incident diabetes with this class of agents, the absolute benefits of statin therapy on cardiovascular events overweigh the risk in patients with moderate or high cardiovascular risk or with documented cardiovascular disease. As with other statins, rosuvastatin is an appropriate therapy in addition to antihypertensive treatment to reduce cardiovascular risk in hypertensive patients.
authors: Department of Medicine and Therapeutics, Chinese University of Hong Kong, Shatin, Hong Kong.
authors: Miao
authors: M
authors: Hu
authors: Brian
authors: B
authors: Tomlinson
keywords: atherosclerosis; cardiovascular disease; lipids; rosuvastatin
references: Atherosclerosis. 2009 Apr;203(2):325-30
references: 18834985
references: Free Radic Res. 2008 Mar;42(3):226-36
references: 18344117
references: Am Heart J. 2008 Mar;155(3):584.e1-8
references: 18294500
references: Hypertens Res. 2011 Jun;34(6):665-73
references: 21512515
references: Hypertension. 2007 Apr;49(4):792-8
references: 17309949
references: AIDS Res Hum Retroviruses. 2013 Mar;29(3):547-56
references: 23098891
references: Atherosclerosis. 2007 Oct;194(2):505-11
references: 17223112
references: J Am Coll Cardiol. 2009 Nov 10;54(20):1850-9
references: 19892235
references: Am J Cardiol. 2003 Jul 15;92(2):152-60
references: 12860216
references: Expert Opin Pharmacother. 2011 Dec;12(17):2599-604
references: 21999752
references: Int J Clin Pract. 2009 Mar;63(3):478-85
references: 19222633
references: N Engl J Med. 2005 Jul 21;353(3):238-48
references: 16034009
references: N Engl J Med. 2009 Apr 2;360(14):1395-407
references: 19332456
references: N Engl J Med. 2011 Dec 1;365(22):2078-87
references: 22085316
references: Expert Opin Drug Saf. 2011 Nov;10(6):969-86
references: 21999163
references: Am J Cardiol. 2010 Jan 1;105(1):69-76
references: 20102893
references: JAMA. 2007 Mar 28;297(12):1344-53
references: 17384434
references: Eur Heart J. 2012 Sep;33(18):2290-6
references: 22513778
references: JAMA. 2011 Jun 22;305(24):2556-64
references: 21693744
references: J Clin Pharmacol. 2002 Oct;42(10):1116-21
references: 12362926
references: Recent Pat Cardiovasc Drug Discov. 2008 Jun;3(2):92-7
references: 18537759
references: Hypertens Res. 2011 Jul;34(7):869-75
references: 21562509
references: Expert Opin Drug Saf. 2007 Sep;6(5):573-81
references: 17877444
references: J Clin Pharmacol. 2008 Aug;48(8):900-8
references: 18524997
references: J Am Coll Cardiol. 2007 Mar 27;49(12):1272-8
references: 17394957
references: N Engl J Med. 2008 Nov 20;359(21):2195-207
references: 18997196
references: Expert Rev Cardiovasc Ther. 2011 Nov;9(11):1383-90
references: 22059787
references: N Engl J Med. 2007 Nov 29;357(22):2248-61
references: 17984166
references: Atherosclerosis. 2003 Dec;171(2):245-53
references: 14644393
references: Eur J Heart Fail. 2012 Sep;14(9):992-9
references: 22740508
references: Am J Cardiovasc Drugs. 2008;8(2):127-46
references: 18422395
references: Circulation. 2004 Nov 9;110(19):3121-8
references: 15520318
references: Circulation. 2008 May 13;117(19):2458-66
references: 18378607
references: Int J Cardiol. 2011 Jan 7;146(1):68-72
references: 20471117
references: Am J Cardiol. 2008 Feb 1;101(3):315-8
references: 18237592
references: Lancet. 2009 Apr 4;373(9670):1175-82
references: 19329177
references: Curr Pharm Des. 2009;15(5):479-89
references: 19199976
references: Pharmacogenetics. 2003 Jan;13(1):19-28
references: 12544509
references: Am J Ther. 2010 May-Jun;17(3):255-62
references: 19918164
references: Int J Cardiol. 2013 Sep 1;167(5):2350-3
references: 23194788
references: Clin Chim Acta. 2006 Nov;373(1-2):99-103
references: 16784736
references: Am J Manag Care. 2001 May;7(5 Suppl):S148-51
references: 11383377
references: JAMA. 2006 Apr 5;295(13):1556-65
references: 16533939
references: Pharmacoepidemiol Drug Saf. 2010 Dec;19(12):1218-24
references: 20922707
references: Lancet. 2010 Feb 27;375(9716):735-42
references: 20167359
references: Am J Cardiol. 2003 Aug 21;92(4B):23K-29K
references: 12948873
references: Clin Ther. 2007 Jul;29(7):1403-14
references: 17825691
references: Adv Ther. 2009 May;26(5):469-87
references: 19444394
references: Eur J Pharmacol. 2008 Aug 20;590(1-3):327-32
references: 18585701
references: Cardiovasc Drugs Ther. 2008 Aug;22(4):321-38
references: 18553127
references: Am J Cardiovasc Drugs. 2010;10(1):11-28
references: 20104931
references: Atherosclerosis. 2012 Apr;221(2):471-7
references: 22304793
references: Circ J. 2009 Nov;73(11):2110-7
references: 19801853
references: BMJ. 2010 May 20;340:c2197
references: 20488911
references: J Cardiovasc Pharmacol Ther. 2013 Jul;18(4):327-33
references: 23364255
references: Intern Med. 2008;47(17):1505-10
references: 18758125
references: Clin Ther. 2003 Aug;25(8):2215-24
references: 14512129
references: Clin Ther. 2003 Nov;25(11):2822-35
references: 14693307
references: Lancet. 2008 Oct 4;372(9645):1231-9
references: 18757089
references: J Lipid Res. 2010 Jun;51(6):1546-53
references: 19965573
references: Drug Metab Dispos. 2013 Mar;41(3):592-601
references: 23248200
references: AIDS. 2012 Sep 10;26(14):1801-5
references: 22739396
references: Am J Cardiol. 2006 Jun 1;97(11):1602-6
references: 16728222
references: Lancet. 2012 Aug 11;380(9841):565-71
references: 22883507
references: J Atheroscler Thromb. 2011;18(11):1018-28
references: 21921413
references: N Engl J Med. 2009 Apr 30;360(18):1851-61
references: 19329822
references: Circulation. 2009 Dec 1;120(22):2188-96
references: 19917888
references: Am J Cardiol. 2013 Apr 15;111(8):1123-30
references: 23352266
references: Lancet. 2004 Jun 26;363(9427):2189-90
references: 15220045
references: Int J Cardiol. 2009 Nov 12;137(3):246-51
references: 18706705
references: Clin Med Insights Cardiol. 2012;6:17-33
references: 22442638
references: Clin Pharmacol Ther. 2009 Aug;86(2):197-203
references: 19474787
references: Cardiology. 2007;107(4):433-43
references: 17363845
references: Lancet. 2007 Aug 18;370(9587):591-603
references: 17707755
references: Lancet. 2007 Nov 24;370(9601):1781-90
references: 17559928
references: Am J Cardiol. 2004 Oct 1;94(7):882-8
references: 15464670
references: Diabetes Care. 2009 Jun;32(6):1087-91
references: 19265025
references: Am Fam Physician. 2011 Mar 15;83(6):711-6
references: 21404982
references: Cardiology. 2004;102(1):52-60
references: 15073451
references: Am J Cardiovasc Drugs. 2010;10(6):383-400
references: 21090831
references: Curr Med Res Opin. 2001;17(1):43-50
references: 11464446
references: Arch Intern Med. 2010 Jun 28;170(12):1032-6
references: 20585068
references: Curr Med Res Opin. 2003;19(6):540-56
references: 14594527
references: Clin Ther. 2003 Oct;25(10):2553-63
references: 14667956